United States Financial Markets News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Search entities
Discover all 32,649 supported financial entities for United States financial markets here.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1318,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "3e08bb10-523a-4374-9902-d97c6e729ac7",
"title": "RDDT INVESTIGATION NOTICE: Reddit, Inc. is being Investigated for Securities Fraud -- Contact BFA Law if You Suffered Losses (NYSE:RDDT)",
"description": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Reddit, Inc. (: RDDT) for po",
"keywords": "GuruFocus, Article, News, Marketwired, RDDT",
"snippet": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Reddit, Inc. (: RDDT) for pote...",
"url": "https://www.gurufocus.com/news/2899906/rddt-investigation-notice-reddit-inc-is-being-investigated-for-securities-fraud-contact-bfa-law-if-you-suffered-losses-nyserddt",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T13:00:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "TSLA",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 15.071484,
"sentiment_score": 0.8555,
"highlights": [
{
"highlight": "Among its recent notable successes, BFA [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "4d0c4ea4-b34a-4cc1-bd34-30529e746cc0",
"title": "CODI CLASS NOTICE: Compass Diversified Holdings Investors may have been Affected by Fraud -- Contact BFA Law before July 8 Court Deadline (NYSE:CODI)",
"description": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Compass Dive",
"keywords": "GuruFocus, Article, News, Marketwired, CODI",
"snippet": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Compass Divers...",
"url": "https://www.gurufocus.com/news/2899904/codi-class-notice-compass-diversified-holdings-investors-may-have-been-affected-by-fraud-contact-bfa-law-before-july-8-court-deadline-nysecodi",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T13:00:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "TL0.DE",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 13.570639,
"sentiment_score": 0.8555,
"highlights": [
{
"highlight": "Among its recent notable successes, BFA [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TSLA",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 13.570639,
"sentiment_score": 0.8555,
"highlights": [
{
"highlight": "Among its recent notable successes, BFA [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "fd99a723-eab5-48ed-a5b6-74f2d1473242",
"title": "CIVI CLASS NOTICE: Civitas Resources, Inc. Investors may have been Affected by Fraud -- Contact BFA Law before July 1 Court Deadline (NYSE:CIVI)",
"description": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Civitas Reso",
"keywords": "GuruFocus, Article, News, Marketwired, CIVI",
"snippet": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Civitas Resour...",
"url": "https://www.gurufocus.com/news/2899905/civi-class-notice-civitas-resources-inc-investors-may-have-been-affected-by-fraud-contact-bfa-law-before-july-1-court-deadline-nysecivi",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T13:00:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "TL0.DE",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 13.570639,
"sentiment_score": 0.8555,
"highlights": [
{
"highlight": "Among its recent notable successes, BFA [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TSLA",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 13.570639,
"sentiment_score": 0.8555,
"highlights": [
{
"highlight": "Among its recent notable successes, BFA [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "404ebe78-d92c-4e8d-bbfa-86a541ae36fb",
"title": "IOVA CLASS NOTICE: Iovance Biotherapeutics, Inc. Investors may have been Affected by Fraud -- Contact BFA Law before July 14 Court Deadline (NASDAQ:IOVA)",
"description": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biot",
"keywords": "GuruFocus, Article, News, Marketwired, IOVA",
"snippet": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biothe...",
"url": "https://www.gurufocus.com/news/2899907/iova-class-notice-iovance-biotherapeutics-inc-investors-may-have-been-affected-by-fraud-contact-bfa-law-before-july-14-court-deadline-nasdaqiova",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T13:00:03.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "IOVA",
"name": "Iovance Biotherapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 141.98395,
"sentiment_score": -0.192729,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+276 characters]",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "If you invested in Iovance you are encou[+259 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Iovance</em> <em>Biotherapeutics</em[+315 characters]",
"sentiment": -0.4019,
"highlighted_in": "main_text"
},
{
"highlight": "Click here if you suffered losses: https[+323 characters]",
"sentiment": -0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "Submit your information by visiting:\n\nht[+212 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "https://www.bfalaw.com/cases-investigati[+149 characters]",
"sentiment": -0.0754,
"highlighted_in": "main_text"
},
{
"highlight": "IOVA CLASS NOTICE: <em>Iovance</em> <em>Biotherapeutics</em>, <em>Inc</em>. Investors may have been Affected by Fraud -- Contact BFA Law before July 14 Court Deadline (<em>NASDAQ:IOVA</em>)",
"sentiment": -0.6597,
"highlighted_in": "title"
}
]
},
{
"symbol": "TL0.DE",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 13.570639,
"sentiment_score": 0.8555,
"highlights": [
{
"highlight": "Among its recent notable successes, BFA [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TSLA",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 13.570639,
"sentiment_score": 0.8555,
"highlights": [
{
"highlight": "Among its recent notable successes, BFA [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "47e0f5bd-4fca-4852-8227-376de859fffc",
"title": "BBAI CLASS NOTICE: BigBear.ai Holdings, Inc. Investors may have been Affected by Fraud -- Contact BFA Law before June 10 Court Deadline (NYSE:BBAI)",
"description": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BigBear.ai H",
"keywords": "GuruFocus, Article, News, Marketwired, BBAI",
"snippet": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BigBear.ai Hol...",
"url": "https://www.gurufocus.com/news/2899902/bbai-class-notice-bigbearai-holdings-inc-investors-may-have-been-affected-by-fraud-contact-bfa-law-before-june-10-court-deadline-nysebbai",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T13:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GIGGU",
"name": "GigCapital4, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 32.20625,
"sentiment_score": 0.0258,
"highlights": [
{
"highlight": "BigBear.ai went public via a special pur[+319 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GIG",
"name": "GigCapital4, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 32.20625,
"sentiment_score": 0.0258,
"highlights": [
{
"highlight": "BigBear.ai went public via a special pur[+319 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GIGGW",
"name": "GigCapital4, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 32.20625,
"sentiment_score": 0.0258,
"highlights": [
{
"highlight": "BigBear.ai went public via a special pur[+319 characters]",
"sentiment": 0.0258,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TL0.DE",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 12.934196,
"sentiment_score": 0.8555,
"highlights": [
{
"highlight": "Among its recent notable successes, BFA [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TSLA",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 12.934196,
"sentiment_score": 0.8555,
"highlights": [
{
"highlight": "Among its recent notable successes, BFA [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "a0b102bf-473d-4926-9eb0-b12daba42826",
"title": "URGN CLASS ACTION NOTICE: UroGen Pharma Ltd. has been Sued for Securities Fraud after Stock Plummets 45% -- Contact BFA Law if You Suffered Losses (NASDAQ:URGN)",
"description": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharm",
"keywords": "GuruFocus, Article, News, Marketwired, URGN",
"snippet": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma ...",
"url": "https://www.gurufocus.com/news/2899903/urgn-class-action-notice-urogen-pharma-ltd-has-been-sued-for-securities-fraud-after-stock-plummets-45-contact-bfa-law-if-you-suffered-losses-nasdaqurgn",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T13:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "URGN",
"name": "UroGen Pharma Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 146.4266,
"sentiment_score": -0.264014,
"highlights": [
{
"highlight": "NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) [+265 characters]",
"sentiment": 0.0516,
"highlighted_in": "main_text"
},
{
"highlight": "If you invested in UroGen you are encour[+248 characters]",
"sentiment": 0.3612,
"highlighted_in": "main_text"
},
{
"highlight": "<em>UroGen</em> <em>Pharma</em> <em>Ltd<[+296 characters]",
"sentiment": -0.743,
"highlighted_in": "main_text"
},
{
"highlight": "Click here if you suffered losses: https[+312 characters]",
"sentiment": -0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "Submit your information by visiting:\n\nht[+202 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "https://www.bfalaw.com/cases-investigati[+139 characters]",
"sentiment": -0.0754,
"highlighted_in": "main_text"
},
{
"highlight": "URGN CLASS ACTION NOTICE: <em>UroGen</em> <em>Pharma</em> <em>Ltd</em>. has been Sued for Securities Fraud after Stock Plummets 45% -- Contact BFA Law if You Suffered Losses (<em>NASDAQ:URGN</em>)",
"sentiment": -0.8176,
"highlighted_in": "title"
}
]
},
{
"symbol": "TL0.DE",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 12.934196,
"sentiment_score": 0.8555,
"highlights": [
{
"highlight": "Among its recent notable successes, BFA [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "TSLA",
"name": "Tesla, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 12.934196,
"sentiment_score": 0.8555,
"highlights": [
{
"highlight": "Among its recent notable successes, BFA [+242 characters]",
"sentiment": 0.8555,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "837508af-d91b-450b-84f4-81db142786f7",
"title": "Moderna (MRNA) Gains FDA Approval for New COVID-19 Vaccine",
"description": "Moderna secures FDA approval for the innovative mNEXSPIKE COVID-19 vaccine. Analysts predict a 76.39% upside potential for Moderna's stock. GuruFocus",
"keywords": "GuruFocus, Article, News, GuruFocus News, MRNA",
"snippet": "Moderna secures FDA approval for the innovative mNEXSPIKE COVID-19 vaccine.\n\nAnalysts predict a 76.39% upside potential for Moderna's stock.\n\nGuruFocus projects...",
"url": "https://www.gurufocus.com/news/2899900/moderna-mrna-gains-fda-approval-for-new-covid19-vaccine",
"image_url": "https://static.gurufocus.com/logos/0C0000BJB3.png?20",
"language": "en",
"published_at": "2025-05-31T12:55:17.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MRNA",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 45.513313,
"sentiment_score": 0.358986,
"highlights": [
{
"highlight": "<em>Moderna</em> secures FDA approval fo[+204 characters]",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> (MRNA, Financial) has r[+250 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "Wall Street Analysts Forecast\n\nAccording[+283 characters]",
"sentiment": -0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "For a deeper dive into these estimates, [+303 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "GuruFocus Valuation Insights\n\nGuruFocus [+212 characters]",
"sentiment": 0.1027,
"highlighted_in": "main_text"
},
{
"highlight": "For more detailed insights, visit the <e[+223 characters]",
"sentiment": 0.6705,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> (MRNA) Gains FDA Approval for New COVID-19 Vaccine",
"sentiment": 0.6705,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "2af23be5-85bd-4549-ae73-aa1811b95b22",
"title": "Moderna wins FDA nod for next-gen COVID shot (MRNA:NASDAQ)",
"description": "Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.",
"keywords": "",
"snippet": "Moderna (NASDAQ:MRNA) announced on Saturday that the U.S. Food and Drug Administration (FDA) approved its next-gen COVID-19 vaccine, mNEXSPIKE (mRNA-1283), maki...",
"url": "https://seekingalpha.com/news/4454033-moderna-wins-fda-nod-next-gen-covid-shot",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1288670274/image_1288670274.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2025-05-31T11:33:27.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "MRNA",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 45.410225,
"sentiment_score": 0.4967,
"highlights": [
{
"highlight": "<em>Moderna</em> (<em>NASDAQ:MRNA</em>) [+295 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> wins FDA nod for next-gen COVID shot (MRNA:NASDAQ)",
"sentiment": 0.5719,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "1288ee00-2918-44e8-8dac-7d1b55a66f14",
"title": "Moderna Inc (MRNA) Secures FDA Approval for mNEXSPIKE COVID-19 Vaccine | MRNA stock news",
"description": "Summary Moderna Inc (MRNA) announced on May 31, 2025, that the U.S. Food and Drug Administration (FDA) has approved its new COVID-19 vaccine, mNEXSPIKE® (mRNA-",
"keywords": "GuruFocus, Article, News, GuruFocus News, MRNA",
"snippet": "Summary\n\nModerna Inc (MRNA, Financial) announced on May 31, 2025, that the U.S. Food and Drug Administration (FDA) has approved its new COVID-19 vaccine, mNEXSP...",
"url": "https://www.gurufocus.com/news/2899894/moderna-inc-mrna-secures-fda-approval-for-mnexspike-covid19-vaccine-mrna-stock-news",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T10:01:11.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MRNA",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 63.439373,
"sentiment_score": 0.33,
"highlights": [
{
"highlight": "Summary\n\n<em>Moderna</em> <em>Inc</em> ([+275 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> plans to make mNEXSPIKE[+252 characters]",
"sentiment": -0.877,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+266 characters]",
"sentiment": 0.9153,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nIn [+273 characters]",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> expects mNEXSPIKE to be[+238 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> <em>Inc</em> (MRNA) Secures FDA Approval for mNEXSPIKE COVID-19 Vaccine | MRNA stock news",
"sentiment": 0.6597,
"highlighted_in": "title"
}
]
},
{
"symbol": "MRNA.MX",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 63.44149,
"sentiment_score": 0.33,
"highlights": [
{
"highlight": "Summary\n\n<em>Moderna</em> <em>Inc</em> ([+275 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> plans to make mNEXSPIKE[+252 characters]",
"sentiment": -0.877,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+266 characters]",
"sentiment": 0.9153,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nIn [+273 characters]",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> expects mNEXSPIKE to be[+238 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> <em>Inc</em> (MRNA) Secures FDA Approval for mNEXSPIKE COVID-19 Vaccine | MRNA stock news",
"sentiment": 0.6597,
"highlighted_in": "title"
}
]
},
{
"symbol": "0A45.L",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 63.44046,
"sentiment_score": 0.33,
"highlights": [
{
"highlight": "Summary\n\n<em>Moderna</em> <em>Inc</em> ([+275 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> plans to make mNEXSPIKE[+252 characters]",
"sentiment": -0.877,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+266 characters]",
"sentiment": 0.9153,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nIn [+273 characters]",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> expects mNEXSPIKE to be[+238 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> <em>Inc</em> (MRNA) Secures FDA Approval for mNEXSPIKE COVID-19 Vaccine | MRNA stock news",
"sentiment": 0.6597,
"highlighted_in": "title"
}
]
},
{
"symbol": "M1RN34.SA",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 63.440987,
"sentiment_score": 0.33,
"highlights": [
{
"highlight": "Summary\n\n<em>Moderna</em> <em>Inc</em> ([+275 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> plans to make mNEXSPIKE[+252 characters]",
"sentiment": -0.877,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Analyst Perspective\n\nFrom a fi[+266 characters]",
"sentiment": 0.9153,
"highlighted_in": "main_text"
},
{
"highlight": "Market Research Analyst Perspective\n\nIn [+273 characters]",
"sentiment": 0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> expects mNEXSPIKE to be[+238 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> <em>Inc</em> (MRNA) Secures FDA Approval for mNEXSPIKE COVID-19 Vaccine | MRNA stock news",
"sentiment": 0.6597,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "1bc3799d-4230-498a-ac8e-9f3749c3fbd7",
"title": "Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE",
"description": "mNEXSPIKE becomes Moderna's third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S",
"keywords": "GuruFocus, Article, News, ACCESSWIRE, NAS:MRNA",
"snippet": "mNEXSPIKE becomes Moderna's third FDA-approved product\n\nCAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U....",
"url": "https://www.gurufocus.com/news/2899891/moderna-receives-us-fda-approval-for-covid19-vaccine-mnexspike",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T09:00:02.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MRNA",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 40.63357,
"sentiment_score": 0.2607,
"highlights": [
{
"highlight": "mNEXSPIKE becomes Moderna's third FDA-ap[+149 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "We appreciate the FDA's timely review an[+104 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> expects to have mNEXSPI[+274 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Moderna</em>\n\n<em>Moderna</em>[+222 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "With a unique culture and a global team [+199 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "For more information about <em>Moderna</[+204 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "IMPORTANT SAFETY INFORMATION\n\nYou should[+248 characters]",
"sentiment": 0.0428,
"highlighted_in": "main_text"
},
{
"highlight": "These risks, uncertainties, and other fa[+251 characters]",
"sentiment": -0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "Except as required by law, <em>Moderna</[+200 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> Contacts\n\nMedia:\n\nChris[+244 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
},
{
"symbol": "M1RN34.SA",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 34.211674,
"sentiment_score": 0.2607,
"highlights": [
{
"highlight": "mNEXSPIKE becomes Moderna's third FDA-ap[+140 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "We appreciate the FDA's timely review an[+104 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> expects to have mNEXSPI[+274 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Moderna</em>\n\n<em>Moderna</em>[+222 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "With a unique culture and a global team [+199 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "For more information about <em>Moderna</[+204 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "IMPORTANT SAFETY INFORMATION\n\nYou should[+248 characters]",
"sentiment": 0.0428,
"highlighted_in": "main_text"
},
{
"highlight": "These risks, uncertainties, and other fa[+251 characters]",
"sentiment": -0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "Except as required by law, <em>Moderna</[+200 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> Contacts\n\nMedia:\n\nChris[+244 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
},
{
"symbol": "MRNA.MX",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 34.211327,
"sentiment_score": 0.2607,
"highlights": [
{
"highlight": "mNEXSPIKE becomes Moderna's third FDA-ap[+140 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "We appreciate the FDA's timely review an[+104 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> expects to have mNEXSPI[+274 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Moderna</em>\n\n<em>Moderna</em>[+222 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "With a unique culture and a global team [+199 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "For more information about <em>Moderna</[+204 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "IMPORTANT SAFETY INFORMATION\n\nYou should[+248 characters]",
"sentiment": 0.0428,
"highlighted_in": "main_text"
},
{
"highlight": "These risks, uncertainties, and other fa[+251 characters]",
"sentiment": -0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "Except as required by law, <em>Moderna</[+200 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> Contacts\n\nMedia:\n\nChris[+244 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
},
{
"symbol": "0A45.L",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 34.210655,
"sentiment_score": 0.2607,
"highlights": [
{
"highlight": "mNEXSPIKE becomes Moderna's third FDA-ap[+140 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "We appreciate the FDA's timely review an[+104 characters]",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> expects to have mNEXSPI[+274 characters]",
"sentiment": 0.4215,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Moderna</em>\n\n<em>Moderna</em>[+222 characters]",
"sentiment": 0.5994,
"highlighted_in": "main_text"
},
{
"highlight": "With a unique culture and a global team [+199 characters]",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "For more information about <em>Moderna</[+204 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "IMPORTANT SAFETY INFORMATION\n\nYou should[+248 characters]",
"sentiment": 0.0428,
"highlighted_in": "main_text"
},
{
"highlight": "These risks, uncertainties, and other fa[+251 characters]",
"sentiment": -0.8442,
"highlighted_in": "main_text"
},
{
"highlight": "Except as required by law, <em>Moderna</[+200 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> Contacts\n\nMedia:\n\nChris[+244 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "b4b39ad2-2f35-44ee-a21f-86c5e500b793",
"title": "Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE | MRNA Stock News",
"description": "Moderna (MRNA) receives FDA approval for its third product, the mNEXSPIKE COVID-19 vaccine. mNEXSPIKE shows 9.3% higher efficacy compared to the origina",
"keywords": "GuruFocus, Article, News, GuruFocus News, MRNA",
"snippet": "Moderna (MRNA, Financial) receives FDA approval for its third product, the mNEXSPIKE COVID-19 vaccine.\n\nmNEXSPIKE shows 9.3% higher efficacy compared to the ori...",
"url": "https://www.gurufocus.com/news/2899872/moderna-receives-us-fda-approval-for-covid19-vaccine-mnexspike-mrna-stock-news",
"image_url": "https://static.gurufocus.com/logos/0C0000BJB3.png?20",
"language": "en",
"published_at": "2025-05-31T05:30:11.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "MRNA",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 37.058163,
"sentiment_score": 0.48685,
"highlights": [
{
"highlight": "<em>Moderna</em> (MRNA, Financial) recei[+317 characters]",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em>, <em>Inc</em>. (MRNA) h[+190 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> plans to introduce mNEX[+312 characters]",
"sentiment": -0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE | MRNA Stock News",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
},
{
"symbol": "MRNA.MX",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 37.058495,
"sentiment_score": 0.48685,
"highlights": [
{
"highlight": "<em>Moderna</em> (MRNA, Financial) recei[+317 characters]",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em>, <em>Inc</em>. (MRNA) h[+190 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> plans to introduce mNEX[+312 characters]",
"sentiment": -0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE | MRNA Stock News",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
},
{
"symbol": "0A45.L",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 37.05841,
"sentiment_score": 0.48685,
"highlights": [
{
"highlight": "<em>Moderna</em> (MRNA, Financial) recei[+317 characters]",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em>, <em>Inc</em>. (MRNA) h[+190 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> plans to introduce mNEX[+312 characters]",
"sentiment": -0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE | MRNA Stock News",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
},
{
"symbol": "M1RN34.SA",
"name": "Moderna, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 37.058945,
"sentiment_score": 0.48685,
"highlights": [
{
"highlight": "<em>Moderna</em> (MRNA, Financial) recei[+317 characters]",
"sentiment": 0.8126,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em>, <em>Inc</em>. (MRNA) h[+190 characters]",
"sentiment": 0.836,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> plans to introduce mNEX[+312 characters]",
"sentiment": -0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Moderna</em> Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE | MRNA Stock News",
"sentiment": 0.4767,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "d6d1b14d-437f-43d9-a6d3-ed7ae974ba66",
"title": "Germany Digital Ministry: Germany's Digital Ministry Considers Controversial 10% Tax on Online Platforms, ET BrandEquity",
"description": "Germany Digital Ministry: Germany's digital ministry is evaluating a potential 10% levy on online platforms like Google and Facebook, citing the need for international coordination and consumer protection, amid concerns of price hikes.",
"keywords": "Germany digital ministry, online platform levy, digital services levy, Wolfram Weimer, Chancellor Friedrich Merz",
"snippet": "Highlights Germany's new digital ministry emphasizes that any levy on online platforms, such as Alphabet Inc.'s Google and Meta Platforms Inc.'s Facebook, must ...",
"url": "https://brandequity.economictimes.indiatimes.com/news/digital/germanys-digital-ministry-considers-controversial-10-tax-on-online-platforms/121534052",
"image_url": "https://etimg.etb2bimg.com/thumb/msid-121534052,imgsize-117320,width-1200,height=765,overlay-etbrandequity/digital/germanys-digital-ministry-considers-controversial-10-tax-on-online-platforms.jpg",
"language": "en",
"published_at": "2025-05-31T12:34:15.000000Z",
"source": "brandequity.economictimes.indiatimes.com",
"relevance_score": null,
"entities": [
{
"symbol": "GOOG",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 10.497809,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Highlights Germany's new digital ministr[+222 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GOOGL",
"name": "Alphabet Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 16.65812,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Highlights Germany's new digital ministr[+222 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "META",
"name": "Meta Platforms Inc",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 13.455133,
"sentiment_score": 0,
"highlights": [
{
"highlight": "s Google and <em>Meta</em> <em>Platforms[+121 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "73d429f6-e170-4004-88ea-06f6187e6b89",
"title": "Match Group: A Love Connection With Value Investors (NASDAQ:MTCH)",
"description": "Match Group faces slowing growth and Tinder headwinds, but new leadership and deep undervaluation offer major upside potential. See why MTCH stock is a buy.",
"keywords": "",
"snippet": "Match Group's ( MTCH ) performance hasn’t been too good. For the last five years, the annual growth rate has been declining by 10% compared to the increase in...",
"url": "https://seekingalpha.com/article/4791423-match-group-a-love-connection-with-value-investors",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1345852206/image_1345852206.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-31T12:29:42.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "MTCH",
"name": "Match Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Communication Services",
"match_score": 43.102535,
"sentiment_score": 0.765,
"highlights": [
{
"highlight": "Match Group: A Love Connection With Value Investors (<em>NASDAQ:MTCH</em>)",
"sentiment": 0.765,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "2a6c3723-4e55-4336-a67f-447af066f6b9",
"title": "Super Micro Computer Stock: Overhyped AI Story With Underwhelming Delivery (NASDAQ:SMCI)",
"description": "Learn why Super Micro Computer's (SMCI) weak Q3 results, poor guidance, and execution risks justify a bearish outlook despite AI infrastructure market growth.",
"keywords": "",
"snippet": "Experience as an investment analyst for a major BB-Bank, as well as private equity consultant for MBB. Currently working towards the CFA charter, having complet...",
"url": "https://seekingalpha.com/article/4791422-super-micro-computer-overhyped-ai-story-with-underwhelming-delivery",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/885294108/image_885294108.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-31T12:19:54.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "SMCI",
"name": "Super Micro Computer, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 109.6831,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Super</em> <em>Micro</em> <em>Computer</em> Stock: Overhyped AI Story With Underwhelming Delivery (<em>NASDAQ:SMCI</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "2c7cfa0d-01bd-45e6-9417-2a6d93a6ac55",
"title": "Hims & Hers Health is laying off staff (HIMS:NYSE)",
"description": "Hims & Hers Health (HIMS) lays off 4% of its workforce as the company adjusted its strategy amid FDA scrutiny on copycat versions of weight loss drugs. Read more here.",
"keywords": "",
"snippet": "Hims & Hers Health (NYSE:HIMS) is laying off about 4% of its employees as the telehealth firm adapts its strategy in a market where the sale of cheaper compound...",
"url": "https://seekingalpha.com/news/4454034-hims-hers-health-is-laying-off-staff",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2164034397/image_2164034397.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2025-05-31T12:18:46.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "HIMS",
"name": "Hims & Hers Health, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 119.218445,
"sentiment_score": -0.08895,
"highlights": [
{
"highlight": "<em>Hims</em> & <em>Hers</em> <em>Health[+233 characters]",
"sentiment": -0.1779,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Hims</em> & <em>Hers</em> <em>Health</em> is laying off staff (HIMS:NYSE)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "864b252f-4058-4206-85b9-f672277cc7f3",
"title": "Shoe Carnival Stock's Transformation Offers Upside (NASDAQ:SCVL)",
"description": "Shoe Carnival stock is undervalued with no debt, strong cash reserves, and growth potential through its premium customer strategy. Read more on SCVL stock here.",
"keywords": "",
"snippet": "Things have been quite ugly for Shoe Carnival (NASDAQ: SCVL ) over the last several months now. Back in July of last year, I decided to reaffirm the company as ...",
"url": "https://seekingalpha.com/article/4791417-shoe-carnival-transformation-offers-upside",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2189251108/image_2189251108.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2025-05-31T12:15:00.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "SCVL",
"name": "Shoe Carnival, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 149.1284,
"sentiment_score": -0.09675,
"highlights": [
{
"highlight": "Things have been quite ugly for <em>Shoe[+296 characters]",
"sentiment": -0.1935,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Shoe</em> <em>Carnival</em> Stock's Transformation Offers Upside (<em>NASDAQ:SCVL</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "19d4e6c3-ceaa-489e-88fc-1f4e7365c3c3",
"title": "Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell Carcinoma (CSCC) Have Potential to Be Practice-Changing",
"description": "**media[642066]**",
"keywords": "Libtayo®, (cemiplimab), Phase, 3, Data, in, the, Adjuvant, Treatment, of, Post-Surgical, High-Risk, Cutaneous, Squamous, Cell, Carcinoma, (CSCC), Have, Potential, to, Be, Practice-Changing",
"snippet": "Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p<0.0001)\n\nLibtayo also demonstrated 80% and...",
"url": "https://www.manilatimes.net/2025/05/31/tmt-newswire/globenewswire/libtayo-cemiplimab-phase-3-data-in-the-adjuvant-treatment-of-post-surgical-high-risk-cutaneous-squamous-cell-carcinoma-cscc-have-potential-to-be-practice-changing/2124535",
"image_url": "https://www.manilatimes.net/manilatimes/uploads/images/2025/05/31/642066.jpg",
"language": "en",
"published_at": "2025-05-31T12:09:42.000000Z",
"source": "manilatimes.net",
"relevance_score": null,
"entities": [
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 27.058697,
"sentiment_score": -0.0757,
"highlights": [
{
"highlight": "., May 31, 2025 (GLOBE NEWSWIRE) -- <em>[+289 characters]",
"sentiment": -0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "You may also report side effects to <em>[+128 characters]",
"sentiment": 0.3182,
"highlighted_in": "main_text"
},
{
"highlight": "About Regeneron\n\nRegeneron (<em>NASDAQ</[+158 characters]",
"sentiment": -0.0772,
"highlighted_in": "main_text"
},
{
"highlight": "Forward-Looking Statements and Use of Di[+219 characters]",
"sentiment": -0.5423,
"highlighted_in": "main_text"
},
{
"highlight": "Financial and other information about Re[+232 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "5e6cd957-328d-4c1c-b6a4-aa2e4f508980",
"title": "Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May",
"description": "Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.",
"keywords": "",
"snippet": "Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.\n\nIn May, U.S. stocks record...",
"url": "https://www.benzinga.com/markets/market-summary/25/05/45709841/benzinga-bulls-and-bears-nvidia-palantir-marvell-technology-and-markets-rallied-in-may",
"image_url": "https://cdn.benzinga.com/files/images/story/2025/05/31/Bulls-and-Bears-1.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2025-05-31T12:04:41.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "GLD",
"name": "SPDR Gold Shares",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 26.803837,
"sentiment_score": -0.4767,
"highlights": [
{
"highlight": ", by Piero Cingari, reports that the <em[+141 characters]",
"sentiment": -0.4767,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ULTA",
"name": "Ulta Beauty, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 36.498344,
"sentiment_score": 0,
"highlights": [
{
"highlight": "\"<em>Ulta</em> <em>Beauty</em> stock cli[+146 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVDA",
"name": "NVIDIA Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 24.628263,
"sentiment_score": 0.302067,
"highlights": [
{
"highlight": "The \"Magnificent Seven\" tech giants led [+283 characters]",
"sentiment": 0.9062,
"highlighted_in": "main_text"
},
{
"highlight": "\"<em>Nvidia</em> stock has ‘significan[+131 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Benzinga Bulls And Bears: <em>Nvidia</em>, Palantir, Marvell Technology — And Markets Rallied In May",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "MRVL",
"name": "Marvell Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 68.188385,
"sentiment_score": 0,
"highlights": [
{
"highlight": "The Bears\n\n\"<em>Marvell</em> <em>Technol[+131 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Benzinga Bulls And Bears: Nvidia, Palantir, <em>Marvell</em> <em>Technology</em> — And Markets Rallied In May",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "REGN",
"name": "Regeneron Pharmaceuticals, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 32.8102,
"sentiment_score": 0,
"highlights": [
{
"highlight": "\"Regeneron, Sanofi stock falls after une[+118 characters]",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SPRO",
"name": "Spero Therapeutics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 15.456009,
"sentiment_score": 0.7783,
"highlights": [
{
"highlight": "For additional bullish calls of the past[+331 characters]",
"sentiment": 0.7783,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NPCE",
"name": "NeuroPace, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 14.674084,
"sentiment_score": 0.2263,
"highlights": [
{
"highlight": "Rocket Pharma's Gene Therapy Future Clou[+257 characters]",
"sentiment": 0.2263,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "3165a8f2-b4ba-4743-8518-2c8b31f8041b",
"title": "Q1 2025 Strauss Group Ltd Earnings Call (Hebrew) Transcript",
"description": "May 28, 2025 / NTS GMTRivka Neufeld - Strauss Group Ltd - Investor Relations Manager Welcome to Strauss Group's First Quarter 2025 Results Earnings Call. On our",
"keywords": "GuruFocus, Article, News, GuruFocus News, XTAE:STRS",
"snippet": "May 28, 2025 / NTS GMT\n\nRivka Neufeld - Strauss Group Ltd - Investor Relations Manager\n\n\n\nWelcome to Strauss Group's First Quarter 2025 Results Earnings Call. O...",
"url": "https://www.gurufocus.com/news/2899899/q1-2025-strauss-group-ltd-earnings-call-hebrew-transcript",
"image_url": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
"language": "en",
"published_at": "2025-05-31T12:00:16.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "SGLJF",
"name": "Strauss Group Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 154.57753,
"sentiment_score": 0.2294,
"highlights": [
{
"highlight": "May 28, 2025 / NTS GMT\n\nRivka Neufeld - [+255 characters]",
"sentiment": 0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "Q1 2025 <em>Strauss</em> <em>Group</em> <em>Ltd</em> Earnings Call (Hebrew) Transcript",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "us",
"total_documents": 1940,
"sentiment_avg": 0.28317706503338136
}
]
}
Other details
Entity count
- 32,649